Influence of converting-enzyme inhibition on rat des-angiotensin I-angiotensinogen
- PMID: 6320670
- DOI: 10.1152/ajpendo.1984.246.2.E129
Influence of converting-enzyme inhibition on rat des-angiotensin I-angiotensinogen
Abstract
The effects of high plasma renin levels on plasma levels of both total immunoreactive angiotensinogen (direct radioimmunoassay) and intact angiotensinogen measured by angiotensin I released by renin (indirect assay) were studied in sodium-depleted rats both with and without captopril treatment and in adrenalectomized rats. The direct assay measures both intact angiotensinogen and des-angiotensin I-angiotensinogen, its residue cleaved by renin. The indirect assay measures only intact angiotensinogen. Neither sodium depletion, captopril treatment, nor adrenalectomy modified the circulating levels of total angiotensinogen. However these treatments produced a decrease in intact angiotensinogen that was in proportion to the elevation of renin levels. The difference between the two assays for angiotensin represents the level of des-angiotensin I-angiotensinogen and correlated satisfactorily with the plasma levels of renin. Identical correlations were observed in adrenalectomized rats and captopril-treated rats. We conclude that des-angiotensin I-angiotensinogen levels are an index of activation of the renin-angiotensin system dependent on the circulating level of renin.
Similar articles
-
Liver angiotensinogen synthesis and release during captopril treatment in sodium-depleted rats.Endocrinology. 1987 Apr;120(4):1384-90. doi: 10.1210/endo-120-4-1384. Endocrinology. 1987. PMID: 3030698
-
The effects of converting enzyme inhibitors on plasma angiotensinogen and plasma aldosterone in sodium-depleted rats.J Hypertens Suppl. 1983 Oct;1(1):37-40. J Hypertens Suppl. 1983. PMID: 6100608
-
[Changes in angiotensinogen and des-angiotensin I-angiotensinogen in man and rat upon inhibition of converting enzyme].Arch Mal Coeur Vaiss. 1982 Jun;75 Spec No:157-61. Arch Mal Coeur Vaiss. 1982. PMID: 6287956 French.
-
The Angiotensin-(1-12)/Chymase axis as an alternate component of the tissue renin angiotensin system.Mol Cell Endocrinol. 2021 Jun 1;529:111119. doi: 10.1016/j.mce.2020.111119. Epub 2020 Dec 10. Mol Cell Endocrinol. 2021. PMID: 33309638 Free PMC article. Review.
-
The brain renin angiotensin system in central cardiovascular control.Contrib Nephrol. 1984;43:114-28. doi: 10.1159/000409947. Contrib Nephrol. 1984. PMID: 6207981 Review. No abstract available.
Cited by
-
Molecular and Pathophysiological Features of Angiotensinogen: A Mini Review.N Am J Med Sci (Boston). 2011 Oct 1;4(4):183-190. doi: 10.7156/v4i4p183. N Am J Med Sci (Boston). 2011. PMID: 22389749 Free PMC article.
-
Uroguanylin, an intestinal natriuretic peptide, is delivered to the kidney as an unprocessed propeptide.Endocrinology. 2008 Sep;149(9):4486-98. doi: 10.1210/en.2007-1725. Epub 2008 May 22. Endocrinology. 2008. PMID: 18499760 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources